Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2017 Oct 25;26(1):37–44. doi: 10.1002/oby.22032

Table 2.

Metabolic characteristics at baseline, after the 6-month interventions, and at 12 months.

Baseline 6 Months 12 Months Group
×
Time
Overall
Group
Overall
Time
6 vs. 0 12 vs. 6 12 vs. 0

N mean±SEM mean±SEM mean±SEM P-value P-value P-value P-value P-value P-value
Triglycerides (mg/dl) WL 34 128 ± 11 113 ± 9 107 ± 8 0.49 0.24 0.000 <0.01 1.0 <0.01
AEX+WL 28 117 ± 7 94 ± 6 94 ± 6

Cholesterol (mg/dl) WL 34 197 ± 7 192 ± 6 204 ± 8 0.49 0.50 0.000 <0.005 <0.005 1.0
AEX+WL 28 198 ± 6 186 ± 5 194 ± 7

LDL-C (mg/dl) WL 34 121 ± 6 116 ± 5 128 ± 7 0.35 0.99 0.000 <0.005 <0.01 1.0
AEX+WL 28 123 ± 5 112 ± 4 118 ± 6

HDL-C (mg/dl) WL 34 55 ± 2 57 ± 2 61 ± 2 0.75 0.38 0.000 <0.01 <0.01 <0.001
AEX+WL 28 52 ± 2 55 ± 2 57 ± 2

Fasting Glucose (mg/dl) WL 31 99 ± 2 92 ± 2 92 ± 2 0.30 0.41 0.000 <0.001 1.0 <0.001
AEX+WL 25 95 ± 2 90 ± 2 92 ± 2

Fasting Insulin (pmol/l) WL 26 93 ± 7 71 ± 5 72 ± 6 0.96 0.24 0.000 <0.001 1.0 <0.01
AEX+WL 18 80 ± 9 59 ± 5 58 ± 5

HOMA-IR WL 25 3.75 ± 0.31 2.75 ± 0.23 2.77 ± 0.26 0.99 0.28 0.000 <0.001 1.0 <0.005
AEX+WL 18 3.16 ± 0.37 2.24 ± 0.22 2.21 ± 0.20

Glucose AUC (mg˙dl−1˙120 min−1) WL 31 17578 ± 645 16492 ± 570 17080 ± 661 0.22 0.12 0.01 <0.05 1.0 <0.05
AEX+WL 25 16364 ± 718 15670 ± 634 15068 ± 736

Insulin AUC (pmol˙l−1˙120 min−1) WL 25 51258 ± 3947 43207 ± 3176 44883 ± 3457 0.09 0.63 0.000 <0.001 1.0 <0.001
AEX+WL 18 55466 ± 4651 41066 ± 3743 36120 ± 4075

Leptin (ng/ml) WL 15 29.2 ± 2.6 22.8 ± 2.4 28.9 ± 3.3 0.27 0.08 0.000 <0.001 <0.005 0.09
AEX+WL 21 25.4 ± 2.2 17.8 ± 2.0 20.1 ± 2.8

Systolic Blood Pressure (mmHg) WL 19 120 ± 3 114 ± 3 116 ± 3 0.93 0.90 0.003 <0.01 0.49 0.62
AEX+WL 20 118 ± 3 114 ± 4 117 ± 4

Diastolic Blood Pressure (mmHg) WL 19 66 ± 2 64 ± 2 66 ± 2 0.57 0.88 0.07 0.06 1.0 0.50
AEX+WL 20 68 ± 2 65 ± 2 65 ± 2